Back to Results
First PageMeta Content
Biosimilar / Biotechnology / Drugs / Declaratory judgment / Biologic / Etanercept / Novartis / Food and Drug Administration / Patent infringement / Pharmacology / Clinical research / Pharmaceutical sciences


Supplement to the Los Angeles and San Francisco AUGUST 27, 2014 BIOTECH: THE BATTLE OVER BIOSIMILARS
Add to Reading List

Document Date: 2014-08-29 13:41:53

Open Document

File Size: 162,99 KB

Share Result on Facebook

City

Los Angeles / /

Company

Celltrion Inc. / Johnson & Johnson / Daily Journal Corporation / Amgen Inc. / Novartis / Janssen Biotech / Genentech Inc. / Celltrion Healthcare Co. / MedImmune Inc. / Sandoz Inc. / Morgan Lewis & Bockius LLP / Hoffmann-La Roche Inc. / /

Continent

Europe / /

Country

United States / /

Currency

USD / /

Event

Patent Issuance / /

Facility

U.S. District Court / /

IndustryTerm

biosimilars applications / healthcare interdisciplinary / licensed reference product / reference product / biosimilar product / biosimilars manufacturer / biological product / biologic products / biosimilar applications / reference products / biosimilar products / /

Organization

U.S. District Court for the District of Massachusetts / Congress / U.S. Supreme Court / U.S. Court of Appeals / UN Court / FDA / U.S. District Court for the Northern District of California / /

Person

Stephen Paul Mahinka / /

/

Position

chair / /

Product

Enbrel / Remicade / /

ProvinceOrState

California / Massachusetts / /

SocialTag